Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) versus Hyperfine (NASDAQ:HYPR) Financial Analysis

Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Valuation and Earnings

This table compares Pheton Holdings Ltd Class A Ordinary Shares and Hyperfine”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton Holdings Ltd Class A Ordinary Shares	$572,291.00	42.21	N/A	N/A	N/A
Hyperfine	$13.26 million	7.04	-$44.24 million	($0.57)	-2.25

Pheton Holdings Ltd Class A Ordinary Shares has higher earnings, but lower revenue than Hyperfine.

Profitability

This table compares Pheton Holdings Ltd Class A Ordinary Shares and Hyperfine’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A
Hyperfine	-309.42%	-57.54%	-50.38%

Analyst Ratings

This is a summary of current ratings for Pheton Holdings Ltd Class A Ordinary Shares and Hyperfine, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton Holdings Ltd Class A Ordinary Shares	0	0	0	0	0.00
Hyperfine	0	1	0	0	2.00

Hyperfine has a consensus price target of $1.60, indicating a potential upside of 25.00%. Given Hyperfine’s stronger consensus rating and higher possible upside, analysts plainly believe Hyperfine is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.

Insider and Institutional Ownership

15.0% of Hyperfine shares are owned by institutional investors. 29.4% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Hyperfine beats Pheton Holdings Ltd Class A Ordinary Shares on 5 of the 9 factors compared between the two stocks.

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.

About Hyperfine

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.